Cancer Channel
Related Channels

Neulasta Warnings and Precautions

To help minimize risks, make sure you understand Neulasta warnings and precautions before taking the drug. Prior to using Neulasta, let your healthcare provider know if you have myeloid cancers or precancerous conditions, sickle cell anemia, or any allergies. It is important to know that Neulasta may potentially cause adult respiratory distress syndrome, stimulate the growth of cancer cells, or worsen sickle cell anemia.

Neulasta: What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to taking Neulasta® (pegfilgrastim) if you have:
  • Sickle cell anemia
  • Myeloid cancers or precancerous conditions, such as:
o Acute myelogenous leukemia (AML), also known as chronic myeloid leukemia
o Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia
o Myelodysplastic syndromes (MDS)
o Myeloproliferative disease
  • Any allergies, including allergies to food, dyes, or preservatives.
Also, let your healthcare provider know if you are:
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
Make sure to tell your healthcare provider about all other medicines you are taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.
7 Natural Ways to Reduce Your Cancer Pain

Neulasta Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.